Krishna M Ella, a molecular biologist and chairman and managing
director of the Bharat Biotech, spoke to TOI's Surendra Singh in an
exclusive interview on the progress made on the vaccine so far.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hope-to-get-nasal-vaccine-against-covid-19-into-market-in-12-18-months-hyderabad-based-bharat-biotech/articleshow/75040665.cms
No comments:
Post a Comment